Product Images Levetiracetam

This appears to be a table showing percentages for different variables. It is not clear what these variables represent as there is no context or column/row headings. Additionally, there is some strange formatting with percentages appearing on separate lines and some random characters at the end. The text is likely a portion of a larger document and without more information it is difficult to provide further context.*

This appears to be a diagram or chart with percentages and labels for "Placeho" and "Levetiracetam 3000 mg/day". The percentage of Levetiracetam 3000 mg/day is 39.4%, while the percentage of Placeho is 14.4%. There are also percentages for 15%, 10%, and 0%. The total number of participants for each group is given (N=104 for Placeho and N=180 for Levetiracetam 3000 mg/day). However, without more context or information about what the study or chart is measuring, it is difficult to provide a more specific description.*

The text provided appears to be the result of data analysis. It shows two percentages, 44.6% and 19.6%, which are associated with Placebo and Levetiracetam, respectively. The sample sizes for each group, N-97 and N-101, are also displayed. It is possible that these figures are part of a study or experiment involving the comparison of the effects of Placebo and Levetiracetam. The nature and scope of the study cannot be determined without further context.*

This is a description of a single-use vial of Levetiracetam injection, USP with a strength of 500mg/5mL (100mg/mL). The vial should be discarded if any portion of it remains unused. The medication should only be administered intravenously and stored at controlled room temperature. The manufacturer is Gland Pharma Limited based in Hyderabad, India. The text also includes various identification codes such as NDC 0409-2011-05 and the trademark Novaplus.*

This is a product description of Levetiracetam injection, USP. The pack contains 25 single-use vials of 5ml, which should have any unused portion discarded. The injection has a strength of 500 mg/5 mL (100 mg/mL) and is for intravenous use only. It must be diluted before administration. The package also contains a single-use vial of 255 mL Levetiracetam injection, USP, containing 500mg/5ml (100mg/mL) Levetiracetam, 52g Sodium Acetate Trihydrate, 45mg Chloride, and Gluconate. The package insert should be reviewed for complete dosage recommendations. The product should be stored at 20-25°C. The manufacturer's name is NovaPlus.*